Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cost and Effectiveness of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients With Peritoneal Carcinoma.

NCT04779385 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT04779385
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04779385 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cost and Effectiveness of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients With Peritoneal Carcinoma.
Lead sponsor
University Hospital, Grenoble
Phase
Observational
Overall status
Completed
Start date
November 16, 2020
Completion date
March 30, 2021
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

evaluate the cost of a pipac procedure and the associated hospital stay in france